Smith Margaret Ekins bought SPRY

September 1, 2026 · Form 4 insider transaction

Smith Margaret Ekins bought 1,001,738 shares of ARS Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

1,001,738

Price

$0.00

Total value

N/A

InsiderSmith Margaret Ekins

RoleOfficer

CompanyARS Pharmaceuticals, Inc. (SPRY)

SecurityStock Option (right to buy)

Transaction codeA: Grant or award

Transaction dateSeptember 1, 2026

Filing dateSeptember 2, 2026

Shares owned after1,001,738

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

25% of the shares subject to the option vest on August 17, 2027, and the remaining shares will vest monthly thereafter over three years.

View the original Form 4 on SEC EDGAR